Clinical Trial Update: A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI [Phase 4]

View source ↗

Summary

Phase 4 randomized, single-blind trial evaluating Cardiomyopeptidin for reducing ischemia-reperfusion injury in patients with ST-segment elevation myocardial in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Cardiomyopeptidin (cardiomyopeptidin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Cardiovascular Diseases | Phase 4 | Status: COMPLETED